Background
We investigated agreement between self-reported prenatal alcohol
exposure (PAE) and objective meconium alcohol markers to determine the
optimal meconium marker and threshold for identifying PAE.
Methods
Meconium fatty acid ethyl esters (FAEE), ethyl glucuronide (EtG), and
ethyl sulfate (EtS) were quantified by liquid chromatography-tandem mass
spectrometry in 0.1 g meconium from infants of Safe Passage Study
participants. Detailed PAE information was collected from women with a
validated timeline follow-back interview. As meconium formation begins
during weeks 12-20, maternal self-reported drinking at or beyond 19 weeks
was our exposure variable.
Results
Of 107 women, 33 reported no alcohol consumption in pregnancy, 16
stopped drinking by week 19, and 58 drank beyond 19 weeks (including 45
3rd trimester drinkers). There was moderate-substantial
agreement between self-reported PAE ≥19 weeks and meconium EtG
≥30 ng/g (kappa: 0.57, 95% CI 0.41-0.73). This biomarker and
associated cutoff was superior to a 7 FAEE sum ≥2 nmol/g and all
other individual and combination marker cutoffs. With meconium EtG
≥30 ng/g as the gold-standard condition and maternal self-report
≥19 weeks gestation as the test condition, 82% sensitivity (95% CI:
71.6-92.0) and 75% specificity (95% CI: 63.2-86.8) were observed. A
significant dose-concentration relationship between self-reported drinks per
drinking day and meconium EtG ≥30 ng/g also was observed
(P<0.01).
Conclusions
We assessed meconium EtG, EtS, and FAEE concentrations in the same
meconium sample and compared concentrations to detailed self-reported PAE
data. Maternal alcohol consumption ≥19 weeks was better represented
by meconium EtG ≥30 ng/g compared to current FAEE cutoffs.